Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

The Empire Strikes Back: NY Accelerates Energy Transition

The Empire State is accelerating renewable energy development as part of its COVID-19 recovery efforts Alicia Barton, President & CEO of NYSERDA (New York State Energy Research & Development Authority), retweeted an article from CleanTechnica yesterday and comme...
Stephan Bogner | April 7, 2020 |

Azarga Gets Thumbs Up from Analysts After Favorable Ruling on NRC License

After receiving a favorable ruling on the NRC license, its focus shifts to project economics. Azarga Uranium Corp. (AZZ:TSX; AZZUF:OTCQB; P8AA:FSE) recently announced that the Atomic Safety and Licensing Board (ASLB) issued its Final Initial Decision, resolving the...
Streetwise Reports | December 27, 2019 |

This China sector is ramping up

Share | "Are you sure this is one of the top hospitals in Beijing? The paint's peeling!" This was my reaction after spending five minutes in a Chinese hospital. I asked our associate to do his best to snap some pictures without anyone noticing. (When your...
Larsen Kusick | October 28, 2012 |

Seabed rare earth and precious metal mining

Rising prices in precious metals and China’s monopoly in rare earth elements are leading to creativity and innovation in mining. For instance, Japan reported last month that they found extremely rich deposits of rare earth minerals on the seabed of the Pa...
Justin Dove | October 28, 2012 |

The Duel Between Johnson and Parliament. Will Gold Win?

Boris Johnson struggles to push the Brexit agreement through the British Parliament. For it can bite back! Who wins this battle? One could hope that gold, but this is not so certain… Johnson’s Struggle, Explained On Thursday, the breaking news came ...
Arkadiusz Sieron | October 23, 2019 |

How Investors Can Jump on the ESG Train

Back in August , we introduced our Stockhouse investor audience to a very different, and very profitable, kind of ESG company that’s been a market leader in Environmental Services – Vertex Resource Group Ltd. ( TSX-V.VTX , Forum ). In this exclusive ...
Dave Jackson | November 4, 2021 |

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...
Jonathon Brown | March 28, 2024 |

Neon Therapeutics Shares Are Flashing Brightly after Reporting Predictive Cancer Breakthrough

After announcing publication in the scientific journal Immunity that it had created a 61-fold improvement process for predicting cancer-specific antigens, Neon Therapeutics' stock has traded wildly today, up more than 46% at times on nearly 100-times average daily volume, bu...
Streetwise Reports | September 9, 2019 |

US Stock Markets Trade Sideways – Waiting on News/Guidance.

Our researchers believe the global concerns centered around Banking and Debt within the Emerging Markets and Asia/Europe are very likely to become major issues over the next 3+ months. These potentially dangerous issues could have far-reaching pricing ramifications for almost ...
Chris Vermeulen | October 8, 2019 |

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher

Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. Yesterday afternoon, Dermira Inc. (DERM:NASDAQ) , a biopharmaceu...
Streetwise Reports | October 21, 2019 |
1 2 3 4 5 6 7 8 9 10